Published in Infect Immun on August 01, 1980
Hemolytic activity in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli. J Clin Microbiol (1980) 1.25
Plasmids coding for colonization factor antigens I and II, heat-labile enterotoxin, and heat-stable enterotoxin A2 in Escherichia coli. Infect Immun (1986) 1.18
Studies on enterotoxigenic Escherichia coli isolated from persons without diarrhoea in Western Australia. J Hyg (Lond) (1983) 0.92
Enterotoxin production, presence of colonization factor antigen I, and adherence to HeLa cells by Escherichia coli O128 strains belonging to different O subgroups. Infect Immun (1985) 0.91
Evaluation of antisera used for detecting enterotoxigenic Escherichia coli in Sao Paulo. J Clin Microbiol (1985) 0.86
Genetic transfer of antimicrobial resistance and enterotoxigenicity among Escherichia coli strains. Antimicrob Agents Chemother (1983) 0.84
Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu. J Infect Dis (1972) 24.30
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Detection of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture. Science (1974) 13.04
Cyclic adenosine monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect Immun (1974) 12.51
Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 9.99
The enterotoxin plasmids of Escherichia coli. J Infect Dis (1974) 9.10
Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model. Infect Immun (1976) 5.86
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Three characteristics associated with enterotoxigenic Escherichia coli isolated from man. Infect Immun (1973) 4.42
Special O:K:H serotypes among enterotoxigenic E. coli strains from diarrhea in adults and children. Occurrence of the CF (colonization factor) antigen and of hemagglutinating abilities. Med Microbiol Immunol (1977) 4.33
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04
Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun (1979) 2.01
Effects of age and ambient temperature on the responses of infant mice to heat-stable enterotoxin of Escherichia coli: assay modifications. Infect Immun (1978) 1.36
Enterotoxigenic Escherichia coli causing infantile enteritis in Britain. Lancet (1977) 1.31
Enterotoxigenic Escherichia coli in central Canada. J Clin Microbiol (1980) 1.11
Prevalence of toxigenic and invasive strains of Escherichia coli in a hospital population. J Infect Dis (1975) 0.98
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med (1992) 18.74
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 17.42
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23
Clonal relationships among Escherichia coli strains that cause hemorrhagic colitis and infantile diarrhea. Infect Immun (1993) 6.72
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol (1985) 4.52
Isolation of Escherichia coli O157:H7 from dairy cattle associated with two cases of haemolytic uraemic syndrome. Lancet (1986) 4.44
Toward a population genetic analysis of Salmonella: genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimurium. Proc Natl Acad Sci U S A (1988) 4.43
Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis (1988) 4.12
Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting. N Engl J Med (1982) 4.03
The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis (1986) 3.96
H7 antiserum-sorbitol fermentation medium: a single tube screening medium for detecting Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol (1985) 3.91
Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88
Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermannii sp. nov. J Clin Microbiol (1982) 3.84
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53
Comparison of plasmid profile analysis, phage typing, and antimicrobial susceptibility testing in characterizing Salmonella typhimurium isolates from outbreaks. J Clin Microbiol (1984) 3.33
Molecular characterization of Vibrio cholerae O1 strains by pulsed-field gel electrophoresis. J Clin Microbiol (1994) 3.27
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med (1981) 3.25
Characterization of biochemically atypical Vibrio cholerae strains and designation of a new pathogenic species, Vibrio mimicus. J Clin Microbiol (1981) 3.19
Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis (1991) 3.12
Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J Clin Microbiol (1993) 3.01
Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Infect Immun (1988) 2.99
Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol (1991) 2.97
Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol (1983) 2.96
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J Infect Dis (1992) 2.62
Effect of antihypertensives on sexual function and quality of life: the TAIM Study. Ann Intern Med (1991) 2.49
Parasitic, bacterial, and viral enteric pathogens associated with diarrhea in the Central African Republic. J Clin Microbiol (1984) 2.46
Extrachromosomal nature of hydrogen sulfide production in Escherichia coli. J Bacteriol (1971) 2.45
Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis. J Clin Microbiol (1987) 2.44
Differential effect of steady versus oscillating flow on bone cells. J Biomech (1998) 2.38
Serotype-specific prevalence of Escherichia coli strains with EPEC adherence factor genes in infants with and without diarrhea in São Paulo, Brazil. J Infect Dis (1989) 2.35
Correlation between adherence to HeLa cells and serogroups, serotypes, and bioserotypes of Escherichia coli. Infect Immun (1985) 2.28
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis (1974) 2.19
Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother (1979) 2.17
Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness. J Clin Microbiol (1991) 2.15
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11
Systolic Hypertension in the Elderly Program (SHEP). Part 1: Rationale and design. Hypertension (1991) 2.04
Aeromonas intestinal infections in the United States. Ann Intern Med (1986) 2.03
Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med (1994) 2.01
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J (2002) 1.98
Biochemical and serological characterization of hydrogen sulfide-positive variants of Escherichia coli. Appl Microbiol (1974) 1.89
Difference between toxigenic Vibrio cholerae O1 from South America and US gulf coast. Lancet (1991) 1.87
Visual acuity of eyes after vitrectomy for retinopathy of prematurity: follow-up at 5 1/2 years. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology (1996) 1.87
Response of rat lung to 3,4-benzpyrene administered by intratracheal instillation in infusine with or without carbon black. Br J Cancer (1975) 1.86
Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates. J Clin Microbiol (1992) 1.86
Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension (1999) 1.83
Detection of Serratia outbreaks in hospital. Lancet (1976) 1.81
Molecular epidemiology of Yersinia enterocolitica O:3 infections: use of chromosomal DNA restriction fragment length polymorphisms of rRNA genes. J Clin Microbiol (1991) 1.80
Isolation of Latin American epidemic strain of Vibrio cholerae O1 from US Gulf Coast. Lancet (1992) 1.80
Influence of the 60-megadalton plasmid on adherence of Escherichia coli O157:H7 and genetic derivatives. Infect Immun (1990) 1.80
Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation (2001) 1.78
Restriction fragment length polymorphisms in the ribosomal genes for species identification and subtyping of aerotolerant Campylobacter species. J Clin Microbiol (1991) 1.77
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis. Proc Natl Acad Sci U S A (1987) 1.72
Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72
A multistate outbreak of infections caused by Yersinia enterocolitica transmitted by pasteurized milk. JAMA (1984) 1.70
Vibriophage VcA-3 as an epidemic strain marker for the U.S. Gulf Coast Vibrio cholerae O1 clone. J Clin Microbiol (1992) 1.68
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Plasmid-mediated properties of a heat-stable enterotoxin-producing Escherichia coli associated with infantile diarrhea. Infect Immun (1976) 1.67
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation (1998) 1.63
Restriction fragment length polymorphisms in rRNA operons for subtyping Shigella sonnei. J Clin Microbiol (1991) 1.63
Genotypic and phenotypic characterization of Helicobacter cinaedi and Helicobacter fennelliae strains isolated from humans and animals. J Clin Microbiol (1995) 1.62
Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J Clin Microbiol (1990) 1.60
Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet (1982) 1.57
The purification and characterization of an extremely thermostable alpha-amylase from the hyperthermophilic archaebacterium Pyrococcus furiosus. J Biol Chem (1993) 1.52
Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med (1982) 1.50
Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine. J Clin Microbiol (1996) 1.48
Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations. J Virol (1986) 1.47
Serological differences between verocytotoxin 2 and shiga-like toxin II. Lancet (1988) 1.46
Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Ann Intern Med (1990) 1.46
Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J Clin Microbiol (1993) 1.41
Campylobacter isolates in the United States, 1982-1986. MMWR CDC Surveill Summ (1988) 1.40
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. Control Clin Trials (2001) 1.39
Toxigenic Vibrio cholerae O1 strain from Mexico identical to United States isolates. Lancet (1983) 1.39
Fatal cutaneous necrosis mimicking calciphylaxis in a patient with type 1 primary hyperoxaluria. Arch Dermatol (1995) 1.39
Ureolytic Escherichia coli of human origin: serological, epidemiological, and genetic analysis. J Clin Microbiol (1979) 1.35
Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II. J Clin Microbiol (1989) 1.35
Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping). J Infect Dis (1992) 1.33
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
DNA probe analysis of diarrhoeagenic Escherichia coli: detection of EAF-positive isolates of traditional enteropathogenic E. coli serotypes among Bangladeshi paediatric diarrhoea patients. Mol Cell Probes (1992) 1.32
Plesiomonas enteric infections in the United States. Ann Intern Med (1986) 1.32
Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology (1991) 1.31
The emerging diversity of the electrophoretic types of Vibrio cholerae in the Western Hemisphere. J Infect Dis (1995) 1.28
Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice. Infect Immun (1989) 1.27
Nosocomial meningitis due to Citrobacter diversus in neonates: new aspects of the epidemiology. J Infect Dis (1984) 1.26